• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Osso VR and ACC to Develop Cardiac Procedure Training with VR

by Fred Pennic 04/05/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Osso VR, the leader in immersive procedural training, announces a groundbreaking collaboration with the American College of Cardiology (ACC) to develop a state-of-the-art training curriculum for left atrial appendage occlusion (LAAO) procedures. 

– The strategic partnership marks a significant leap forward in the field of medical education, leveraging virtual reality (VR) technology to enhance interventional cardiologists’ training.

The Focus: Left Atrial Appendage Occlusion (LAAO)

The co-developed curriculum focuses on LAAO, a critical procedure that reduces stroke risk in patients with atrial fibrillation. Mastering LAAO requires a diverse skillset, including Transesophageal Echocardiography (TEE). Osso VR’s immersive platform addresses this by providing:

  • Realistic and Engaging VR Simulation: Users can practice LAAO procedures in a risk-free, virtual environment, replicating real-world scenarios with high fidelity.
  • Comprehensive Live Imaging: The platform integrates live imaging, mimicking a real patient’s responses, for a truly immersive training experience.
  • Refined Instrument Control: Osso VR’s technology allows for precise and realistic manipulation of virtual instruments, ensuring users develop the necessary dexterity for successful procedures.

“ACC’s goal is to improve access to high-quality cardiovascular care. We are thrilled to collaborate with Osso VR to augment traditional interventional training for some of the more complex and cutting-edge procedures in our field,” said Ami Bhatt, MD, FACC, ACC Chief Innovation Officer. “This collaboration is the first step in a broader effort to increase access to consistent interventional cardiovascular care in the U.S. and globally.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Immersive Virtual Reality

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |